NIH-funded research NIH-funded research

Understanding how arginine methylation affects cell signaling

Official title: A Functional Analysis of Arginine Methylation

Funded at University of Tx Md Anderson Can Ctr · NIH-10842017 · Data updated 2026-11-12

This study is looking at how a small change in proteins, called arginine methylation, affects how cells work and respond to things like DNA damage, and it's for anyone interested in understanding more about how our cells communicate and function.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 1, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$405,000
NIH project number1R35GM153387-01
Project IDNIH-10842017 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to DNA damage or signaling pathway disruptions.

Less likely to help

Patients with conditions unrelated to arginine methylation or those not experiencing issues with DNA damage may not benefit from this research.

What this research studies

This research investigates the biological roles of arginine methylation, a common modification that affects protein function and communication within cells. The team will explore how this modification is recognized by specific proteins and its impact on cellular processes, including responses to DNA damage. By using advanced techniques such as proteomic screens and mouse models, the researchers aim to fill knowledge gaps regarding the effects of arginine methylation and its role in signaling pathways.

Why it matters

Potential benefit: If successful, this research could lead to new insights into cellular communication and potential therapeutic targets for diseases related to DNA damage and signaling dysfunction.

How similar studies have gone: Previous research has shown promising results in understanding the roles of other post-translational modifications, suggesting potential for success in this area as well.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Bedford, Mark T. — University of Tx Md Anderson Can Ctr
  • Study coordinator: Bedford, Mark T.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.